Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-08-042855
Filing Date
2008-07-17
Accepted
2008-07-17 17:21:43
Documents
1
Period of Report
2008-07-14

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c73961_3.html 3  
1 MAIN DOCUMENT DESCRIPTION c73961_3.xml 3 2642
  Complete submission text file 0001209191-08-042855.txt   4756
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT ST, SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 972-4-988-9488
Bar-Shalev Amos (Reporting) CIK: 0001385113 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 08957780